Abstract
Sepsis is a common clinical disease. The NLRP3 inflammasome is a multiprotein complex that is involved in both innate and adaptive immune responses. However, the expression of NLRP3 in patients with sepsis has not been elucidated. 98 patients with sepsis before and after treatment were selected and 106 healthy volunteers were used as the control group. PBMCs were isolated from each group to measure NLRP3 and Caspase 1 level Real time PCR. The expression of serum procalcitonin (PCT), C-reactive protein (CRP), IL-1β and IL-18 was analyzed by ELISA. NLRP3 and Caspase 1 level was significantly increased in sepsis patients before treatment with increased secretion of IL-1β and IL-18 in serum and elevated level of PCT and CRP (P < 0.05). NLRP3, Caspase 1 expression, IL-1β and IL-18 secretion were positively correlated with serum PCT and CRP in patients with sepsis (P < 0.05). After treatment, NLRP3 and Caspase 1 mRNA expression was significantly decreased and serum IL-1β and IL-18 secretion was significantly decreased (P < 0.05). NLRP3 is increased in sepsis and IL-1β and IL-18 secretion is elevated, implying the involvement of NLRP3 in the occurrence and development of sepsis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.